Matteo Biagetti

Person

Verona, IT

People

Patents Grantslast 30 patents

Information Patent Grant
Pyrazole derivatives as phosphoinositide 3-kinases inhibitors
- Patent number 10,189,844
- Issue date Jan 29, 2019
- CHIESI FARMACEUTICI S.P.A.
- Matteo Biagetti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chromene derivatives as phoshoinositide 3-kinases inhibitors
- Patent number 9,968,604
- Issue date May 15, 2018
- CHIESI FARMACEUTICI S.P.A.
- Anna Maria Capelli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridazinone derivatives as phoshoinositide 3-kinases inhibitors
- Patent number 9,745,308
- Issue date Aug 29, 2017
- CHIESI FARMACEUTICI S.P.A.
- Matteo Biagetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indolizine derivatives as phoshoinositide 3-kinases inhibitors
- Patent number 9,527,869
- Issue date Dec 27, 2016
- CHIESI FARMACEUTICI S.P.A.
- Matteo Biagetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isochromene derivatives as phoshoinositide 3-kinases inhibitors
- Patent number 9,321,776
- Issue date Apr 26, 2016
- CHIESI FARMACEUTICI S.P.A.
- Matteo Biagetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having muscarinic receptor antagonist and beta2 Adrenergi...
- Patent number 8,877,774
- Issue date Nov 4, 2014
- CHIESI FARMACEUTICI S.P.A.
- Fabio Rancati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinoline and quinazoline derivatives having affinity for 5HT1-type...
- Patent number 7,732,600
- Issue date Jun 8, 2010
- Glaxo Group Limited
- Markus Bergauer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinazoline derivatives having affinity for 5HT1-type...
- Patent number 7,592,346
- Issue date Sep 22, 2009
- Glaxo Group Limited
- Markus Bergauer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinazoline derivatives having affinity for 5HT1-type...
- Patent number 7,459,456
- Issue date Dec 2, 2008
- Glaxo Group Limited
- Matteo Biagetti
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PYRIDO OXAZINE AMINO DERIVATIVES AS ALK5 INHIBITORS
- Publication number 20240190891
- Publication date Jun 13, 2024
- Chiesi Farmaceutici s.p.A.
- Daniele PALA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS
- Publication number 20240116947
- Publication date Apr 11, 2024
- Chiesi Farmaceutici s.p.A.
- Daniele PALA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS
- Publication number 20240116948
- Publication date Apr 11, 2024
- Chiesi Farmaceutici s.p.A.
- Daniele PALA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS
- Publication number 20240025880
- Publication date Jan 25, 2024
- Chiesi Farmaceutici s.p.A.
- Claudio FIORELLI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS
- Publication number 20240018122
- Publication date Jan 18, 2024
- Chiesi Farmaceutici s.p.A.
- Daniela PIZZIRANI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHTHALAZINE DERIVATIVES AS P2X3 INHIBITORS
- Publication number 20240002371
- Publication date Jan 4, 2024
- Chiesi Farmaceutici s.p.A.
- Claudio FIORELLI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
(AZA)QUINOLINE 4-AMINES DERIVATIVES AS P2X3 INHIBITORS
- Publication number 20230416233
- Publication date Dec 28, 2023
- Chiesi Farmaceutici s.p.A.
- Claudio FIORELLI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDOPYRIMIDINES DERIVATIVES AS P2X3 INHIBITORS
- Publication number 20230212169
- Publication date Jul 6, 2023
- Chiesi Farmaceutici s.p.A.
- Paolo BRUNO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS
- Publication number 20230092892
- Publication date Mar 23, 2023
- Chiesi Farmaceutici s.p.A.
- Paolo BRUNO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDOPYRIMIDINES DERIVATIVES AS P2X3 INHIBITORS
- Publication number 20220235060
- Publication date Jul 28, 2022
- Chiesi Farmaceutici s.p.A.
- Paolo BRUNO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS
- Publication number 20220227749
- Publication date Jul 21, 2022
- Chiesi Farmaceutici s.p.A.
- Paolo BRUNO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS
- Publication number 20220175784
- Publication date Jun 9, 2022
- Chiesi Farmaceutici s.p.A.
- Matteo BIAGETTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS
- Publication number 20170226109
- Publication date Aug 10, 2017
- Chiesi Farmaceutici s.p.A.
- Matteo BIAGETTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS
- Publication number 20160303123
- Publication date Oct 20, 2016
- Chiesi Farmaceutici s.p.A.
- Anna Maria CAPELLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDAZINONE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS
- Publication number 20160075710
- Publication date Mar 17, 2016
- Chiesi Farmaceutici s.p.A.
- Matteo BIAGETTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDOLIZINE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS
- Publication number 20150361100
- Publication date Dec 17, 2015
- Chiesi Farmaceutici s.p.A.
- Matteo BIAGETTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOCHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS
- Publication number 20150166549
- Publication date Jun 18, 2015
- Chiesi Farmaceutici s.p.A.
- Matteo Biagetti
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...
- Publication number 20130045169
- Publication date Feb 21, 2013
- Chiesi Farmaceutici s.p.A.
- Fabio Rancati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED TRICYCLIC DERIVATIVES FOR THE TREATMENT OF PSYCHOTIC DISORDERS
- Publication number 20120022056
- Publication date Jan 26, 2012
- Jonathan Bentley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of...
- Publication number 20100286151
- Publication date Nov 11, 2010
- Jonathan Bentley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Benzimidazoles With A Hetero Spiro-Decane Residue As NPY-Y5 Antagon...
- Publication number 20100216821
- Publication date Aug 26, 2010
- Nicholas Paul Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type...
- Publication number 20100204273
- Publication date Aug 12, 2010
- Glaxo Group Limited
- Markus Bergauer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5)...
- Publication number 20100197699
- Publication date Aug 5, 2010
- Glaxo Group Limited
- Jonathan Bentley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE...
- Publication number 20090312546
- Publication date Dec 17, 2009
- Glaxo Group Limited
- Markus Bergauer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Spiro Compounds As NPY Y5 Receptor Antagonists
- Publication number 20090203705
- Publication date Aug 13, 2009
- Matteo Biagetti
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chemical Compounds
- Publication number 20090042897
- Publication date Feb 12, 2009
- Glaxo Group Limited
- Jonathan Bentley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE...
- Publication number 20080280919
- Publication date Nov 13, 2008
- Glaxo Group Limited
- Markus Bergauer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE...
- Publication number 20070167423
- Publication date Jul 19, 2007
- Glaxo Group Limited
- Markus Bergauer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline and quinazoline derivatives having affinity for 5ht1-type...
- Publication number 20060229312
- Publication date Oct 12, 2006
- Markus Bergauer
- C07 - ORGANIC CHEMISTRY

Matteo Biagetti

Person

Patents Grantslast 30 patents

Pyrazole derivatives as phosphoinositide 3-kinases inhibitors

Chromene derivatives as phoshoinositide 3-kinases inhibitors

Pyridazinone derivatives as phoshoinositide 3-kinases inhibitors

Indolizine derivatives as phoshoinositide 3-kinases inhibitors

Isochromene derivatives as phoshoinositide 3-kinases inhibitors

Compounds having muscarinic receptor antagonist and beta2 Adrenergi...

Quinoline and quinazoline derivatives having affinity for 5HT1-type...

Quinoline and quinazoline derivatives having affinity for 5HT1-type...

Quinoline and quinazoline derivatives having affinity for 5HT1-type...

Patents Applicationslast 30 patents

PYRIDO OXAZINE AMINO DERIVATIVES AS ALK5 INHIBITORS

PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS

PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS

PHTHALAZINE DERIVATIVES AS P2X3 INHIBITORS

(AZA)QUINOLINE 4-AMINES DERIVATIVES AS P2X3 INHIBITORS

PYRIDOPYRIMIDINES DERIVATIVES AS P2X3 INHIBITORS

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

PYRIDOPYRIMIDINES DERIVATIVES AS P2X3 INHIBITORS

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS

PYRAZOLE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS

CHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS

PYRIDAZINONE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS

INDOLIZINE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS

ISOCHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS

COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...

FUSED TRICYCLIC DERIVATIVES FOR THE TREATMENT OF PSYCHOTIC DISORDERS

1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of...

Benzimidazoles With A Hetero Spiro-Decane Residue As NPY-Y5 Antagon...

Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type...

I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5)...

QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE...

Spiro Compounds As NPY Y5 Receptor Antagonists

Chemical Compounds

QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE...

QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE...

Quinoline and quinazoline derivatives having affinity for 5ht1-type...